Life Science Compliance Update

July

2018

Copay Assistance Lands Pfizer Another Corporate Integrity Agreement

Written by , Posted in Uncategorized

Kaitlin Fallon Wildoner, Esq.

Pfizer is the second company (of perhaps many) to find itself in a new corporate integrity agreement (CIA) over patient assistance programs and independent charities. The CIA entered between Pfizer and HHS-OIG, and the DOJ include some newer language and requirements centering around PAPs and give good insight into what other companies should be looking to do concerning their PAP arrangements.


   or   

  • Return to July 2018 LSC Update Table of Contents
  • Copy abstract URL
  • Order Reprints

  • February

    2018

    When Good Intentions Go Astray – United Therapeutics Settles AKS Suit

    Written by , Posted in Uncategorized

    Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

    With the United Therapeutics settlement, it is clear that the DOJ remains focused on patient assistance programs and other similar charities. As a result, additional settlements involving these programs are likely to continue in 2018, once more pitting established legal constructs against current fiscal realities.


       or   


    Menu Title